SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001023024-08-000023
Filing Date
2008-11-10
Accepted
2008-11-10 16:24:28
Documents
3
Period of Report
2008-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BIOSANTE 8K FOR Q3 2008 RESULTS q320088k.htm 8-K 26181
2 NEWS RELEASE newsreleaseq32008.htm EX-99.1 11051
3 LOGO bpaxlogo1.jpg GRAPHIC 8292
  Complete submission text file 0001023024-08-000023.txt   50440
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 081175961
SIC: 2836 Biological Products, (No Diagnostic Substances)